Publications

Publications

Get to one year’s publications by clicking the calendar date

2024,2023, 2022, 2021, 2020, 2019, 2018, 2017, 2016, 2015, 2014, 2013, 2012, 2011, 2010, 2009, 2008, 2007, 2006, 2005, 2004, 2003, 2002, 2001, 2000, 1999, 1998, 1997, 1996, 1995, 1994, 1993, 1992, 1991, 1990, 1989, 1988, 1986, 1983 bold are our lab members and our visiting scientists, most recent articles are at the top

2024

 

2023

2022

2021

2020

2019

2018

  • Rizvi I, Nath S, Obaid G, Ruhi MK, Moore K, Bano S, Kessel D, Hasan T. A Combination of Visudyne and a Lipid-Anchored Liposomal Formulation of Benzoporphyrin Derivative Enhances Photodynamic Therapy Efficacy in a 3D Model for Ovarian Cancer. Photochem Photobiol. 2018 Nov 29.
  • Pigula M, Huang HC, Mallidi S, Anbil S, Liu J, Mai Z, Hasan T. Size-dependent Tumor Response to Photodynamic Therapy and Irinotecan Monotherapies Revealed by Longitudinal Ultrasound Monitoring in an Orthotopic Pancreatic Cancer Model. Photochem Photobiol. 2018 Sep 19.
  • Liu H, Daly L, Rudd G, Khan AP, Mallidi S, Liu Y, Cuckov F, Hasan T, Celli JP. Development and evaluation of a low-cost, portable, LED-based device for PDT treatment of early-stage oral cancer in resource-limited settings. Lasers Surg Med. 2018 Aug 31.
  • Huang HC, Pigula M, Fang Y, Hasan T. Immobilization of Photo-Immunoconjugates on Nanoparticles Leads to Enhanced Light-Activated Biological Effects. Small. 2018 Jul 1:e1800236
  • Marra K, LaRochelle EP, Chapman MS, Hoopes PJ, Lukovits K, Maytin EV, Hasan T, Pogue BW. “Comparison of Blue and White Lamp Light with Sunlight for Daylight-Mediated, 5-ALA Photodynamic Therapy, in vivo.”, Photochem Photobiol. 2018 Apr 16.
  • Rizvi I, Obaid G, Bano S, Hasan T, Kessel D. “Photodynamic therapy: Promoting in vitro efficacy of photodynamic therapy by liposomal formulations of a photosensitizing agent.”, Lasers Surg Med. 2018 Mar 11.
  • Broekgaarden M, Rizvi I, Bulin AL, Petrovic L, Goldschmidt R, Massodi I, Celli JP, Hasan T. “Neoadjuvant photodynamic therapy augments immediate and prolonged oxaliplatin efficacy in metastatic pancreatic cancer organoids.”, Oncotarget. 2018 Feb 6;9(16):13009-13022.
  • Huang HC, Liu J, Baglo Y, Rizvi I, Anbil S, Pigula M, Hasan T. “Mechanism-informed Repurposing of Minocycline Overcomes Resistance to Topoisomerase Inhibition for Peritoneal Carcinomatosis.”, Mol Cancer Ther. 2018 Feb;17(2):508-520.
  • Huang HC, Rizvi I, Liu J, Anbil S, Kalra A, Lee H, Baglo Y, Paz N, Hayden D, Pereira S, Pogue BW, Fitzgerald J, Hasan T. “Photodynamic Priming Mitigates Chemotherapeutic Selection Pressures and Improves Drug Delivery.”, Cancer Res. 2018 Jan 15;78(2):558-571.

2017

  • Bulin AL, Broekgaarden M, Hasan T. “Comprehensive high-throughput image analysis for therapeutic efficacy of architecturally complex heterotypic organoids.”, Sci Rep 2017 Nov 30;7(1):16645.
  • Huang HC, Liu J, Baglo Y, Rizvi I, Anbil S, Pigula M, Hasan T. “Mechanism informed repurposing of minocycline overcomes resistance to topoisomerase inhibition for peritoneal carcinomatosis.”, Mol Cancer Ther. 2017 Nov 22.
  • de Souza ALR, LaRochelle E, Marra K, Gunn J, Davis SC, Samkoe KS, Chapman MS, Maytin EV, Hasan T, Pogue BW. “Assessing daylight & low-light photodynamic therapy efficacy, using biomarkers of photophysical, biochemical and biological damage metrics in situ.”, Photodiagnosis Photodyn Ther. 2017 Oct 13.
  • Nieskoski MD, Marra K, Gunn JR, Hoopes PJ, Doyley MM, Hasan T, Trembly BS, Pogue BW. “Collagen Complexity Spatially Defines Microregions of Total Tissue Pressure in Pancreatic Cancer.”, Sci Rep. 2017 Aug 30.
  • Obaid G, Spring BQ, Bano S, Hasan T. “Activatable clinical fluorophore-quencher antibody pairs as dual molecular probes for the enhanced specificity of image-guided surgery.”, J Biomed Opt. 2017 Aug;22(12):1-6.
  • Nieskoski MD, Marra K, Gunn JR, Kanick SC, Doyley MM, Hasan T, Pereira SP, Stuart Trembly B, Pogue BW. “Separation of Solid Stress From Interstitial Fluid Pressure in Pancreas Cancer Correlates With Collagen Area Fraction.”, J Biomech Eng. 2017 Jun 1;139(6).
  • Anand S, Rollakanti KR, Brankov N, Brash DE, Hasan T, Maytin EV. “Fluorouracil enhances photodynamic therapy of squamous cell carcinoma via a p53 -independent mechanism that increases protoporphyrin IX levels and tumor cell death.”, Mol Cancer Ther. 2017 Mar 23.
  • Lee HH, Choi MG, Hasan T. “Application of photodynamic therapy in gastrointestinal disorders: an outdated or re-emerging technique?”, Korean J Intern Med. 2017 Jan;32(1):1-10.

2016

  • Mallidi S, Anbil S, Bulin AL, Obaid G, Ichikawa M, Hasan T. “Beyond the Barriers of Light Penetration: Strategies, Perspectives and Possibilities for Photodynamic Therapy.”, Theranostics. 2016 Oct 23;6(13):2458-2487.
  • de Souza AL, Marra K, Gunn J, Samkoe KS, Kanick SC, Davis SC, Chapman MS, Maytin EV, Hasan T, Pogue BW. “Comparing desferrioxamine and light fractionation enhancement of ALA-PpIX photodynamic therapy in skin cancer.”, Br J Cancer 2016 Sep 27;115(7):805-13.
  • Obaid G, Broekgaarden M, Bulin AL, Huang HC, Kuriakose J, Liu J, Hasan T. “Photonanomedicine: a convergence of photodynamic therapy and nanotechnology.”, Nanoscale 2016 Jul 7;8(25):12471-503.
  • Pogue BW, Paulsen KD, Samkoe KS, Elliott JT, Hasan T, Strong TV, Draney DR, Feldwisch J. “Vision 20/20: Molecular-guided surgical oncology based upon tumor metabolism or immunologic phenotype: Technological pathways for point of care imaging and intervention.”, Med Phys 2016 Jun;43(6):3143.
  • Palanisami A, Khan S, Erdem SS, Hasan T. “Guiding Empiric Treatment for Serious Bacterial Infections via Point of Care β-Lactamase Characterization.”, IEEE J Transl Eng Health Med. 2016 Jun 29;4:2800410.
  • Wang S, Hüttmann G, Scholzen T, Zhang Z, Vogel A, Hasan T, Rahmanzadeh R. “A light-controlled switch after dual targeting of proliferating tumor cells via the membrane receptor EGFR and the nuclear protein Ki-67.”, Sci Rep 2016 Jun 1;6:27032.
  • Kim IW, Park JM, Roh YJ, Kim JH, Choi MG, Hasan T. “Direct measurement of singlet oxygen by using a photomultiplier tube-based detection system.”, J Photochem Photobiol B 2016 Jun; 159:14-23.
  • Spring BQ, Sears BR, Zheng LZ, Mai Z, Watanabe R, Sherwood ME, Schoenfeld DA, Pogue BW, Pereira SP, Villa E, Hasan T. “A photoactivable multi-inhibitor nanoliposome for tumour control and simultaneous inhibition of treatment escape pathways.”, Nat Nanotechnol 2016 Apr;11(4):378-87.
  • Pogue BW, Elliott JT, Kanick SC, Davis SC, Samkoe KS, Maytin EV, Pereira SP, Hasan T. “Revisiting photodynamic therapy dosimetry: reductionist & surrogate approaches to facilitate clinical success.”, Phys Med Biol 2016 Apr 7;61(7):R57-89.
  • Huang HC, Mallidi S, Liu J, Chiang CT, Mai Z, Goldschmidt R, Ebrahim-Zadeh N, Rizvi I, Hasan T. “Photodynamic therapy synergizes with irinotecan to overcome compensatory mechanisms and improve treatment outcomes in pancreatic cancer.”, Cancer Res 2016 Mar 1;76(5):1066-77.

2015

  • Tangutoori S, Spring BQ, Mai Z, Palanisami A, Mensah LB, Hasan T. Simultaneous delivery of cytotoxic and biologic therapeutics using nanophotoactivatable liposomes enhances treatment efficacy in a mouse model of pancreatic cancer. Nanomedicine. 2016 Jan;12(1):223-34. doi: 10.1016/j.nano.2015.08.007. Epub 2015 Sep 25. PMID: 26390832; PMCID: PMC4728029.
  • T. Kushibiki, Y. Tu, A. O. Abu-Yousif, T. Hasan, “Photodynamic activation as a molecular switch to promote osteoblast cell differentiation via AP-1 activation.”, Sci Rep, Aug. 2015.
  • S. Wang, G. Hüttmann, Z. Zhang, A. Vogel, R. Birngruber, S. Tangutoori, T. Hasan, R. Ramanzadeh, “Light-Controlled Delivery of Monoclonal Antibodies for Targeted Photoinactivation of Ki-67.”, Mol Pharm, Sep. 2015.
  • J. H. Kim, J. M. Park, Y. J. Roh, I. W. Kim, T. Hasan, M. G. Choi, “Enhanced efficacy of photodynamic therapy by inhibiting ABCG2 in colon cancers.”, BMC Cancer, Jul. 2015.
  • J. Hempstead, D. P. Jones, A. Ziouche, G. M. Cramer, I. Rizvi, S. Arnason, T. Hasan, J. P. Celli, “Low-cost photodynamic therapy devices for global health settings: Characterization of battery-powered LED performance and smartphone imaging in 3D tumor models.”, Sci Rep, May 2015.
  • S. Mallidi, Z. Mai, J. Hempstead, S. Arnason, J. Celli, T. Hasan, “In vivo evaluation of battery-operated light-emitting diode-based photodynamic therapy efficacy using tumor volume and biomarker expression as endpoints.”, J Biomed Opt, Apr. 2015.
  • B. Q. Spring, I. Rizvi, N. Xu, and T. Hasan, “The role of photodynamic therapy in overcoming cancer drug resistance.”, Photochem Photobiol Sci, Apr. 2015.
  • S. Mallidi, K. Watanabe, D. Timerman, D. Schoenfeld, and T. Hasan, “Prediction of tumor recurrence and therapy monitoring using ultrasound-guided photoacoustic imaging.”, Theranostics, vol. 5, no. 3, 2015.
  • S. Mallidi, B. Q. Spring, S. Chang, B. Vakoc, and T. Hasan, “Optical Imaging, Photodynamic Therapy and Optically Triggered Combination Treatments.,” Cancer J, vol. 21, no. 3, Jun. 2015.
  • J. T. Elliott, K. S. Samkoe, J. R. Gunn, E. E. Stewart, T. B. Gardner, K. M. Tichauer, T.-Y. Lee, P. J. Hoopes, S. P. Pereira, T. Hasan, and B. W. Pogue, “Perfusion CT estimates photosensitizer uptake and biodistribution in a rabbit orthotopic pancreatic cancer model: a pilot study.,” Acad Radiol, vol. 22, no. 5, pp. 572–579, May 2015.

2014

  • K. M. Tichauer, M. Diop, J. T. Elliott, K. S. Samkoe, T. Hasan, K. St Lawrence, and B. W. Pogue, “Accounting for pharmacokinetic differences in dual-tracer receptor density imaging.,” Phys Med Biol, vol. 59, no. 10, pp. 2341–2351, May 2014.
  • K. M. Tichauer, K. S. Samkoe, J. R. Gunn, S. C. Kanick, P. J. Hoopes, R. J. Barth, P. A. Kaufman, T. Hasan, and B. W. Pogue, “Microscopic lymph node tumor burden quantified by macroscopic dual-tracer molecular imaging.,” Nat Med, vol. 20, no. 11, pp. 1348–1353, Nov. 2014.
  • K. M. Tichauer, S. J. Deharvengt, K. S. Samkoe, J. R. Gunn, M. W. Bosenberg, M.-J. Turk, T. Hasan, R. V. Stan, and B. W. Pogue, “Tumor endothelial marker imaging in melanomas using dual-tracer fluorescence molecular imaging.,” Mol Imaging Biol, vol. 16, no. 3, pp. 372–382, Jun. 2014.
  • B. Q. Spring, A. Palanisami, and T. Hasan, “Microscale receiver operating characteristic analysis of micrometastasis recognition using activatable fluorescent probes indicates leukocyte imaging as a critical factor to enhance accuracy.,” J Biomed Opt, vol. 19, no. 6, Jun. 2014.
  • B. Q. Spring, A. O. Abu-Yousif, A. Palanisami, I. Rizvi, X. Zheng, Z. Mai, S. Anbil, R. B. Sears, L. B. Mensah, R. Goldschmidt, S. S. Erdem, E. Oliva, and T. Hasan, “Selective treatment and monitoring of disseminated cancer micrometastases in vivo using dual-function, activatable immunoconjugates.,” Proc Natl Acad Sci U S A, vol. 111, no. 10, pp. E933–942, Mar. 2014.
  • K. S. Samkoe, K. M. Tichauer, J. R. Gunn, W. A. Wells, T. Hasan, and B. W. Pogue, “Quantitative in vivo immunohistochemistry of epidermal growth factor receptor using a receptor concentration imaging approach.,” Cancer Res, vol. 74, no. 24, pp. 7465–7474, Dec. 2014.
  • S. Mallidi, S. Anbil, S. Lee, D. Manstein, S. Elrington, G. Kositratna, D. Schoenfeld, B. Pogue, S. J. Davis, and T. Hasan, “Photosensitizer fluorescence and singlet oxygen luminescence as dosimetric predictors of topical 5-aminolevulinic acid photodynamic therapy induced clinical erythema.,” J Biomed Opt, vol. 19, no. 2, Feb. 2014.
  • S. Khan, U. W. Sallum, X. Zheng, G. J. Nau, and T. Hasan, “Rapid optical determination of beta-lactamase and antibiotic activity.,” BMC Microbiol, vol. 14, 2014.
  • S. C. Kanick, S. C. Davis, Y. Zhao, T. Hasan, E. V. Maytin, B. W. Pogue, and M. S. Chapman, “Dual-channel red/blue fluorescence dosimetry with broadband reflectance spectroscopic correction measures protoporphyrin IX production during photodynamic therapy of actinic keratosis.,” J Biomed Opt, vol. 19, no. 7, 2014.
  • M. Jermyn, S. C. Davis, H. Dehghani, M. T. Huggett, T. Hasan, S. P. Pereira, S. G. Bown, and B. W. Pogue, “CT contrast predicts pancreatic cancer treatment response to verteporfin-based photodynamic therapy.,” Phys Med Biol, vol. 59, no. 8, pp. 1911–1921, Apr. 2014.
  • M. T. Huggett, M. Jermyn, A. Gillams, R. Illing, S. Mosse, M. Novelli, E. Kent, S. G. Bown, T. Hasan, B. W. Pogue, and S. P. Pereira, “Phase I/II study of verteporfin photodynamic therapy in locally advanced pancreatic cancer.,” Br J Cancer, vol. 110, no. 7, pp. 1698–1704, Apr. 2014.
  • N. Hamzei, K. S. Samkoe, J. T. Elliott, R. W. Holt, J. R. Gunn, T. Hasan, B. W. Pogue, and K. M. Tichauer, “Comparison of Kinetic Models for Dual-Tracer Receptor Concentration Imaging in Tumors.,” Austin J Biomed Eng, vol. 1, no. 1, Mar. 2014.
  • A. A. Ghogare, I. Rizvi, T. Hasan, and A. Greer, “‘Pointsource’ delivery of a photosensitizer drug and singlet oxygen: eradication of glioma cells in vitro.,” Photochem Photobiol, vol. 90, no. 5, pp. 1119–1125, Oct. 2014.
  • M. Frenette, M. Hatamimoslehabadi, S. Bellinger-Buckley, S. Laoui, J. La, S. Bag, S. Mallidi, T. Hasan, B. Bouma, C. Yelleswarapu, and J. Rochford, “Shining light on the dark side of imaging: excited state absorption enhancement of a bis-styryl BODIPY photoacoustic contrast agent.,” J Am Chem Soc, vol. 136, no. 45, pp. 15853–15856, Nov. 2014.
  • S. S. Erdem, S. Khan, A. Palanisami, and T. Hasan, “Rapid, low-cost fluorescent assay of beta-lactamase-derived antibiotic resistance and related antibiotic susceptibility.,” J Biomed Opt, vol. 19, no. 10, 2014.
  • J. P. Celli, I. Rizvi, A. R. Blanden, I. Massodi, M. D. Glidden, B. W. Pogue, and T. Hasan, “An imaging-based platform for high-content, quantitative evaluation of therapeutic response in 3D tumour models.,” Sci Rep, vol. 4, 2014.
  • S. Anand, K. R. Rollakanti, R. L. Horst, T. Hasan, and E. V. Maytin, “Combination of oral vitamin D3 with photodynamic therapy enhances tumor cell death in a murine model of cutaneous squamous cell carcinoma.,” Photochem Photobiol, vol. 90, no. 5, pp. 1126–1135, Oct. 2014.

2013

  • S. Torosean, B. Flynn, J. Axelsson, J. Gunn, K. S. Samkoe, T. Hasan, M. M. Doyley, and B. W. Pogue, “Nanoparticle uptake in tumors is mediated by the interplay of vascular and collagen density with interstitial pressure.,” Nanomedicine, vol. 9, no. 2, pp. 151–158, Feb. 2013.
  • B. Q. Spring, A. Palanisami, L. Z. Zheng, A. E. Blatt, B. Sears, and T. Hasan, “Efficient measurement of total tumor microvascularity ex vivo using a mathematical model to optimize volume subsampling,” Journal of Biomedical Optics, vol. 18, no. 9, 2013.
  • K. S. Samkoe, A. Bryant, J. R. Gunn, S. P. Pereira, T. Hasan, and B. W. Pogue, “Contrast enhanced-magnetic resonance imaging as a surrogate to map verteporfin delivery in photodynamic therapy.,” J Biomed Opt, vol. 18, no. 12, Dec. 2013.
  • I. Rizvi, U. A. Gurkan, S. Tasoglu, N. Alagic, J. P. Celli, L. B. Mensah, Z. Mai, U. Demirci, and T. Hasan, “Flow induces epithelial-mesenchymal transition, cellular heterogeneity and biomarker modulation in 3D ovarian cancer nodules.,” Proc Natl Acad Sci U S A, vol. 110, no. 22, pp. E1974–1983, May 2013.
  • I. Rizvi, S. Anbil, N. Alagic, J. Celli, L. Z. Zheng, A. Palanisami, M. D. Glidden, B. W. Pogue, and T. Hasan, “PDT dose parameters impact tumoricidal durability and cell death pathways in a 3D ovarian cancer model.,” Photochem Photobiol, vol. 89, no. 4, pp. 942–952, Aug. 2013.
  • Y. Mir, S. A. Elrington, and T. Hasan, “A new nanoconstruct for epidermal growth factor receptor-targeted photo-immunotherapy of ovarian cancer.,” Nanomedicine, vol. 9, no. 7, pp. 1114–1122, Oct. 2013.
  • D. K. Dhar, S. W. M. Olde Damink, J. H. Brindley, A. Godfrey, M. H. Chapman, N. S. Sandanayake, F. Andreola, S. Mazurek, T. Hasan, M. Malago, and S. P. Pereira, “Pyruvate kinase M2 is a novel diagnostic marker and predicts tumor progression in human biliary tract cancer.,” Cancer, vol. 119, no. 3, pp. 575–585, Feb. 2013.
  • S. C. Davis, K. S. Samkoe, K. M. Tichauer, K. J. Sexton, J. R. Gunn, S. J. Deharvengt, T. Hasan, and B. W. Pogue, “Dynamic dual-tracer MRI-guided fluorescence tomography to quantify receptor density in vivo.,” Proc Natl Acad Sci U S A, vol. 110, no. 22, pp. 9025–9030, May 2013.
  • D. Bartusik, D. Aebisher, A. Ghogare, G. Ghosh, I. Abramova, T. Hasan, and A. Greer, “A fiberoptic (photodynamic therapy type) device with a photosensitizer and singlet oxygen delivery probe tip for ovarian cancer cell killing.,” Photochem Photobiol, vol. 89, no. 4, pp. 936–941, Aug. 2013.
  • S. Anbil, I. Rizvi, J. P. Celli, N. Alagic, B. W. Pogue, and T. Hasan, “Impact of treatment response metrics on photodynamic therapy planning and outcomes in a three-dimensional model of ovarian cancer.,” J Biomed Opt, vol. 18, no. 9, Sep. 2013.
  • S. Anand, T. Hasan, and E. V. Maytin, “Mechanism of differentiation-enhanced photodynamic therapy for cancer: upregulation of coproporphyrinogen oxidase by C/EBP transcription factors.,” Mol Cancer Ther, vol. 12, no. 8, pp. 1638–1650, Aug. 2013.

2012

  • K. M. Tichauer, K. S. Samkoe, W. S. Klubben, T. Hasan, and B. W. Pogue, “Advantages of a dual-tracer model over reference tissue models for binding potential measurement in tumors.,” Phys Med Biol, vol. 57, no. 20, pp. 6647–6659, Oct. 2012.
  • K. M. Tichauer, K. S. Samkoe, K. J. Sexton, S. K. Hextrum, H. H. Yang, W. S. Klubben, J. R. Gunn, T. Hasan, and B. W. Pogue, “In vivo quantification of tumor receptor binding potential with dual-reporter molecular imaging.,” Mol Imaging Biol, vol. 14, no. 5, pp. 584–592, Oct. 2012.
  • K. M. Tichauer, K. S. Samkoe, K. J. Sexton, J. R. Gunn, T. Hasan, and B. W. Pogue, “Improved tumor contrast achieved by single time point dual-reporter fluorescence imaging.,” J Biomed Opt, vol. 17, no. 6, Jun. 2012.
  • K. S. Samkoe, K. Sexton, K. M. Tichauer, S. K. Hextrum, O. Pardesi, S. C. Davis, J. A. O’Hara, P. J. Hoopes, T. Hasan, and B. W. Pogue, “High vascular delivery of EGF, but low receptor binding rate is observed in AsPC-1 tumors as compared to normal pancreas.,” Mol Imaging Biol, vol. 14, no. 4, pp. 472–479, Aug. 2012.
  • I. Rizvi, T. A. Dinh, W. Yu, Y. Chang, M. E. Sherwood, and T. Hasan, “Photoimmunotherapy and irradiance modulation reduce chemotherapy cycles and toxicity in a murine model for ovarian carcinomatosis: perspective and results.,” Isr J Chem, vol. 52, no. 8–9, Sep. 2012.
  • E. V. Maytin, G. Honari, A. Khachemoune, C. R. Taylor, B. Ortel, B. W. Pogue, N. Sznycer-Taub, and T. Hasan, “Vitamin D Combined with Aminolevulinate (ALA)-Mediated Photodynamic Therapy (PDT) for Human Psoriasis: A Proof-of-Principle Study.,” Isr J Chem, vol. 52, no. 8–9, Sep. 2012.
  • S. Kimani, G. Ghosh, A. Ghogare, B. Rudshteyn, D. Bartusik, T. Hasan, and A. Greer, “Synthesis and characterization of mono-, di-, and tri-poly(ethylene glycol) chlorin e6 conjugates for the photokilling of human ovarian cancer cells.,” J Org Chem, vol. 77, no. 23, pp. 10638–10647, Dec. 2012.
  • T. Hasan, “Using cellular mechanisms to develop effective combinations of photodynamic therapy and targeted therapies.,” J Natl Compr Canc Netw, vol. 10 Suppl 2, pp. S23–26, Oct. 2012.
  • M. D. Glidden, J. P. Celli, I. Massodi, I. Rizvi, B. W. Pogue, and T. Hasan, “Image-Based Quantification of Benzoporphyrin Derivative Uptake, Localization, and Photobleaching in 3D Tumor Models, for Optimization of PDT Parameters.,” Theranostics, vol. 2, no. 9, pp. 827–839, 2012.
  • S. Anand, B. J. Ortel, S. P. Pereira, T. Hasan, and E. V. Maytin, “Biomodulatory approaches to photodynamic therapy for solid tumors.,” Cancer Lett, vol. 326, no. 1, Dec. 2012.
  • A. O. Abu-Yousif, A. C. E. Moor, X. Zheng, M. D. Savellano, W. Yu, P. K. Selbo, and T. Hasan, “Epidermal growth factor receptor-targeted photosensitizer selectively inhibits EGFR signaling and induces targeted phototoxicity in ovarian cancer cells.,” Cancer Lett, vol. 321, no. 2, pp. 120–127, Aug. 2012.

2011

  • F. Xu, J. Celli, I. Rizvi, S. Moon, T. Hasan, and U. Demirci, “A three-dimensional in vitro ovarian cancer coculture model using a high-throughput cell patterning platform.,” Biotechnol J, vol. 6, no. 2, pp. 204–212, Feb. 2011.
  • S. Kosaka, N. Miyoshi, O. E. Akilov, T. Hasan, and S. Kawana, “Targeting of sebaceous glands by delta-aminolevulinic acid-based photodynamic therapy: An in vivo study.,” Lasers Surg Med, vol. 43, no. 5, pp. 376–381, Jul. 2011.
  • K. H. Kim, B. H. Park, Y. Tu, T. Hasan, B. Lee, J. Li, and J. F. de Boer, “Polarization-sensitive optical frequency domain imaging based on unpolarized light.,” Opt Express, vol. 19, no. 2, pp. 552–561, Jan. 2011.
  • C. L. Evans, A. O. Abu-Yousif, Y. J. Park, O. J. Klein, J. P. Celli, I. Rizvi, X. Zheng, and T. Hasan, “Killing hypoxic cell populations in a 3D tumor model with EtNBS-PDT.,” PLoS One, vol. 6, no. 8, 2011.
  • J. P. Celli, N. Solban, A. Liang, S. P. Pereira, and T. Hasan, “Verteporfin-based photodynamic therapy overcomes gemcitabine insensitivity in a panel of pancreatic cancer cell lines.,” Lasers Surg Med, vol. 43, no. 7, pp. 565–574, Sep. 2011.
  • A. Casas, G. Di Venosa, T. Hasan, and A. Batlle, “Mechanisms of resistance to photodynamic therapy.,” Curr Med Chem, vol. 18, no. 16, pp. 2486–2515, 2011.
  • S. Anand, C. Wilson, T. Hasan, and E. V. Maytin, “Vitamin D3 enhances the apoptotic response of epithelial tumors to aminolevulinate-based photodynamic therapy.,” Cancer Res, vol. 71, no. 18, pp. 6040–6050, Sep. 2011.
  • O. E. Akilov, M. X. Wu, Y. Jin, Z. Zhou, L. J. Geskin, L. D. Falo, and T. Hasan, “Vaccination with photodynamic therapy-treated macrophages induces highly suppressive T-regulatory cells.,” Photodermatol Photoimmunol Photomed, vol. 27, no. 2, Apr. 2011.

2010

  • K. S. Samkoe, A. Chen, I. Rizvi, J. A. O’Hara, P. J. Hoopes, S. P. Pereira, T. Hasan, and B. W. Pogue, “Imaging tumor variation in response to photodynamic therapy in pancreatic cancer xenograft models.,” Int J Radiat Oncol Biol Phys, vol. 76, no. 1, pp. 251–259, Jan. 2010.
  • U. W. Sallum, X. Zheng, S. Verma, and T. Hasan, “Rapid functional definition of extended spectrum beta-lactamase activity in bacterial cultures via competitive inhibition of fluorescent substrate cleavage.,” Photochem Photobiol, vol. 86, no. 6, pp. 1267–1271, Dec. 2010.
  • I. Rizvi, J. P. Celli, C. L. Evans, A. O. Abu-Yousif, A. Muzikansky, B. W. Pogue, D. Finkelstein, and T. Hasan, “Synergistic enhancement of carboplatin efficacy with photodynamic therapy in a three-dimensional model for micrometastatic ovarian cancer.,” Cancer Res, vol. 70, no. 22, pp. 9319–9328, Nov. 2010.
  • P. Rai, S. Mallidi, X. Zheng, R. Rahmanzadeh, Y. Mir, S. Elrington, A. Khurshid, and T. Hasan, “Development and applications of photo-triggered theranostic agents.,” Adv Drug Deliv Rev, vol. 62, no. 11, pp. 1094–1124, Aug. 2010.
  • R. Rahmanzadeh, P. Rai, J. P. Celli, I. Rizvi, B. Baron-Luhr, J. Gerdes, and T. Hasan, “Ki-67 as a molecular target for therapy in an in vitro three-dimensional model for ovarian cancer.,” Cancer Res, vol. 70, no. 22, pp. 9234–9242, Nov. 2010.
  • B. W. Pogue, K. S. Samkoe, S. Hextrum, J. A. O’Hara, M. Jermyn, S. Srinivasan, and T. Hasan, “Imaging targeted-agent binding in vivo with two probes.,” J Biomed Opt, vol. 15, no. 3, Jun. 2010.
  • E. Latorre-Esteves, O. E. Akilov, P. Rai, S. M. Beverley, and T. Hasan, “Monitoring the efficacy of antimicrobial photodynamic therapy in a murine model of cutaneous leishmaniasis using L. major expressing GFP.,” J Biophotonics, vol. 3, no. 5–6, pp. 328–335, Jun. 2010.
  • S. Kosaka, M. Yasumoto, O. E. Akilov, T. Hasan, and S. Kawana, “Comparative split-face study of 5-aminolevulinic acid photodynamic therapy with intense pulsed light for photorejuvenation of Asian skin.,” J Dermatol, vol. 37, no. 12, pp. 1005–1010, Dec. 2010.
  • C. Joo, C. L. Evans, T. Stepinac, T. Hasan, and J. F. de Boer, “Diffusive and directional intracellular dynamics measured by field-based dynamic light scattering.,” Opt Express, vol. 18, no. 3, pp. 2858–2871, Feb. 2010.
  • J. D. Gruber, A. Paliwal, V. Krishnaswamy, H. Ghadyani, M. Jermyn, J. A. O’Hara, S. C. Davis, J. S. Kerley-Hamilton, N. W. Shworak, E. V. Maytin, T. Hasan, and B. W. Pogue, “System development for high frequency ultrasound-guided fluorescence quantification of skin layers.,” J Biomed Opt, vol. 15, no. 2, Apr. 2010.
  • S. L. Gibbs-Strauss, K. S. Samkoe, J. A. O’Hara, S. C. Davis, P. J. Hoopes, T. Hasan, and B. W. Pogue, “Detecting epidermal growth factor receptor tumor activity in vivo during cetuximab therapy of murine gliomas.,” Acad Radiol, vol. 17, no. 1, Jan. 2010.
  • J. P. Celli, B. Q. Spring, I. Rizvi, C. L. Evans, K. S. Samkoe, S. Verma, B. W. Pogue, and T. Hasan, “Imaging and photodynamic therapy: mechanisms, monitoring, and optimization.,” Chem Rev, vol. 110, no. 5, pp. 2795–2838, May 2010.
  • J. P. Celli, I. Rizvi, C. L. Evans, A. O. Abu-Yousif, and T. Hasan, “Quantitative imaging reveals heterogeneous growth dynamics and treatment-dependent residual tumor distributions in a three-dimensional ovarian cancer model.,” J Biomed Opt, vol. 15, no. 5, Oct. 2010.
  • A. O. Abu-Yousif, E. C. Hett, A. M. Skoczenski, and T. Hasan, “The ABC’s of industry: a postdoc program provides a sneak peek into industry careers.,” Nat Biotechnol, vol. 28, no. 6, pp. 625–626, Jun. 2010.

2009

  • W. Zhong, J. P. Celli, I. Rizvi, Z. Mai, B. Q. Spring, S. H. Yun, and T. Hasan, “In vivo high-resolution fluorescence microendoscopy for ovarian cancer detection and treatment monitoring.,” Br J Cancer, vol. 101, no. 12, pp. 2015–2022, Dec. 2009.
  • X. Zheng, U. W. Sallum, S. Verma, H. Athar, C. L. Evans, and T. Hasan, “Exploiting a bacterial drug-resistance mechanism: a light-activated construct for the destruction of MRSA.,” Angew Chem Int Ed Engl, vol. 48, no. 12, pp. 2148–2151, 2009.
  • P. Xu, E. Gullotti, L. Tong, C. B. Highley, D. R. Errabelli, T. Hasan, J.-X. Cheng, D. S. Kohane, and Y. Yeo, “Intracellular drug delivery by poly(lactic-co-glycolic acid) nanoparticles, revisited.,” Mol Pharm, vol. 6, no. 1, Feb. 2009.
  • S. Verma, U. W. Sallum, H. Athar, L. Rosenblum, J. W. Foley, and T. Hasan, “Antimicrobial photodynamic efficacy of side-chain functionalized benzo[a]phenothiazinium dyes.,” Photochem Photobiol, vol. 85, no. 1, pp. 111–118, Feb. 2009.
  • V. Krishnaswamy, P. J. Hoopes, K. S. Samkoe, J. A. O’Hara, T. Hasan, and B. W. Pogue, “Quantitative imaging of scattering changes associated with epithelial proliferation, necrosis, and fibrosis in tumors using microsampling reflectance spectroscopy.,” J Biomed Opt, vol. 14, no. 1, Feb. 2009.
  • S. L. Gibbs-Strauss, J. A. O’Hara, S. Srinivasan, P. J. Hoopes, T. Hasan, and B. W. Pogue, “Diagnostic detection of diffuse glioma tumors in vive with molecular fluorescent probe-based transmission spectroscopy.,” Med Phys, vol. 36, no. 3, pp. 974–983, Mar. 2009.
  • S. L. Gibbs-Strauss, J. A. O’Hara, P. J. Hoopes, T. Hasan, and B. W. Pogue, “Noninvasive measurement of aminolevulinic acid-induced protoporphyrin IX fluorescence allowing detection of murine glioma in vivo.,” J Biomed Opt, vol. 14, no. 1, Feb. 2009.
  • C. L. Evans, I. Rizvi, T. Hasan, and J. F. de Boer, “In vitro ovarian tumor growth and treatment response dynamics visualized with time-lapse OCT imaging.,” Opt Express, vol. 17, no. 11, pp. 8892–8906, May 2009.
  • S. Anand, G. Honari, T. Hasan, P. Elson, and E. V. Maytin, “Low-dose methotrexate enhances aminolevulinate-based photodynamic therapy in skin carcinoma cells in vitro and in vivo.,” Clin Cancer Res, vol. 15, no. 10, pp. 3333–3343, May 2009.
  • O. E. Akilov, W. Yousaf, S. X. Lukjan, S. Verma, and T. Hasan, “Optimization of topical photodynamic therapy with 3,7-bis(di-n-butylamino)phenothiazin-5-ium bromide for cutaneous leishmaniasis.,” Lasers Surg Med, vol. 41, no. 5, pp. 358–365, Jul. 2009.
  • O. E. Akilov, I. V. Ustyugova, L. Zhi, T. Hasan, and M. X. Wu, “Enhanced susceptibility to Leishmania infection in resistant mice in the absence of immediate early response gene X-1.,” J Immunol, vol. 183, no. 12, Dec. 2009.
  • A. O. Abu-Yousif, I. Rizvi, C. L. Evans, J. P. Celli, and T. Hasan, PuraMatrix encapsulation of cancer cells. United States, 2009.

2008

  • S. E. Waisbren, H. Bowles, T. Hasan, K. H. Zou, S. J. Emans, C. Goldberg, S. Gould, D. Levine, E. Lieberman, M. Loeken, J. Longtine, C. Nadelson, A. F. Patenaude, D. Quinn, A. G. Randolph, J. M. Solet, N. Ullrich, R. Walensky, P. Weitzman, and H. Christou, “Gender differences in research grant applications and funding outcomes for medical school faculty.,” J Womens Health (Larchmt), vol. 17, no. 2, pp. 207–214, Mar. 2008.
  • A. K. Styer, B. T. Sullivan, M. Puder, D. Arsenault, J. C. Petrozza, T. Serikawa, S. Chang, T. Hasan, R. R. Gonzalez, and B. R. Rueda, “Ablation of leptin signaling disrupts the establishment, development, and maintenance of endometriosis-like lesions in a murine model.,” Endocrinology, vol. 149, no. 2, pp. 506–514, Feb. 2008.
  • B. W. Pogue, C. Sheng, J. Benevides, D. Forcione, B. Puricelli, N. Nishioka, and T. Hasan, “Protoporphyrin IX fluorescence photobleaching increases with the use of fractionated irradiation in the esophagus.,” J Biomed Opt, vol. 13, no. 3, Jun. 2008.
  • S. Lee, L. Zhu, A. M. Minhaj, M. F. Hinds, D. H. Vu, D. I. Rosen, S. J. Davis, and T. Hasan, “Pulsed diode laser-based monitor for singlet molecular oxygen.,” J Biomed Opt, vol. 13, no. 3, Jun. 2008.
  • S. Lee, D. H. Vu, M. F. Hinds, S. J. Davis, A. Liang, and T. Hasan, “Pulsed diode laser-based singlet oxygen monitor for photodynamic therapy: in vivo studies of tumor-laden rats.,” J Biomed Opt, vol. 13, no. 6, Dec. 2008.
  • H.-J. Laubach, S. K. Chang, S. Lee, I. Rizvi, D. Zurakowski, S. J. Davis, C. R. Taylor, and T. Hasan, “In-vivo singlet oxygen dosimetry of clinical 5-aminolevulinic acid photodynamic therapy.,” J Biomed Opt, vol. 13, no. 5, Oct. 2008.
  • S. K. Chang, I. Rizvi, N. Solban, and T. Hasan, “In vivo optical molecular imaging of vascular endothelial growth factor for monitoring cancer treatment.,” Clin Cancer Res, vol. 14, no. 13, pp. 4146–4153, Jul. 2008.
  • A. Casas, G. Di Venosa, S. Vanzulli, C. Perotti, L. Mamome, L. Rodriguez, M. Simian, A. Juarranz, O. Pontiggia, T. Hasan, and A. Batlle, “Decreased metastatic phenotype in cells resistant to aminolevulinic acid-photodynamic therapy.,” Cancer Lett, vol. 271, no. 2, pp. 342–351, Nov. 2008.
  • O. E. Akilov, S. Kosaka, E. V. Maytin, and T. Hasan, “Prospects for the use of differentiation-modulating agents as adjuvant of photodynamic therapy for proliferative dermatoses.,” J Dermatol, vol. 35, no. 4, Apr. 2008.

2007

  • X. Zhou, B. Chen, P. J. Hoopes, T. Hasan, and B. W. Pogue, “Peptide-induced inflammatory increase in vascular permeability improves photosensitizer delivery and intersubject photodynamic treatment efficacy.,” Radiat Res, vol. 168, no. 3, Sep. 2007.
  • S. Verma, G. M. Watt, Z. Mai, and T. Hasan, “Strategies for enhanced photodynamic therapy effects.,” Photochem Photobiol, vol. 83, no. 5, Oct. 2007.
  • C. Sheng, P. J. Hoopes, T. Hasan, and B. W. Pogue, “Photobleaching-based dosimetry predicts deposited dose in ALA-PpIX PDT of rodent esophagus.,” Photochem Photobiol, vol. 83, no. 3, pp. 738–748, Jun. 2007.
  • N. Sato, B. W. Moore, S. Keevey, J. A. Drazba, T. Hasan, and E. V. Maytin, “Vitamin D enhances ALA-induced protoporphyrin IX production and photodynamic cell death in 3-D organotypic cultures of keratinocytes.,” J Invest Dermatol, vol. 127, no. 4, pp. 925–934, Apr. 2007.
  • K. O’Riordan, O. E. Akilov, S. K. Chang, J. W. Foley, and T. Hasan, “Real-time fluorescence monitoring of phenothiazinium photosensitizers and their anti-mycobacterial photodynamic activity against Mycobacterium bovis BCG in in vitro and in vivo models of localized infection.,” Photochem Photobiol Sci, vol. 6, no. 10, pp. 1117–1123, Oct. 2007.
  • S. Kosaka, O. E. Akilov, K. O’Riordan, and T. Hasan, “A mechanistic study of delta-aminolevulinic acid-based photodynamic therapy for cutaneous leishmaniasis.,” J Invest Dermatol, vol. 127, no. 6, pp. 1546–1549, Jun. 2007.
  • O. E. Akilov, S. Kosaka, K. O’Riordan, and T. Hasan, “Photodynamic therapy for cutaneous leishmaniasis: the effectiveness of topical phenothiaziniums in parasite eradication and Th1 immune response stimulation.,” Photochem Photobiol Sci, vol. 6, no. 10, pp. 1067–1075, Oct. 2007.
  • O. E. Akilov, S. Kosaka, K. O’Riordan, and T. Hasan, “Parasiticidal effect of delta-aminolevulinic acid-based photodynamic therapy for   cutaneous leishmaniasis is indirect and mediated through the killing of the host cells.,” Exp Dermatol, vol. 16, no. 8, pp. 651–660, Aug. 2007.
  • O. E. Akilov, A. Khachemoune, and T. Hasan, “Clinical manifestations and classification of Old World cutaneous leishmaniasis.,” Int J Dermatol, vol. 46, no. 2, pp. 132–142, Feb. 2007.
  • O. E. Akilov, M. J. Donovan, T. Stepinac, C. R. Carter, J. P. Whitcomb, T. Hasan, and M. A. McDowell, “T helper type 1 cytokines and keratinocyte growth factor play a critical role in pseudoepitheliomatous hyperplasia initiation during cutaneous leishmaniasis.,” Arch Dermatol Res, vol. 299, no. 7, pp. 315–325, Sep. 2007.

2006

  • X. Zhou, B. W. Pogue, B. Chen, E. Demidenko, R. Joshi, J. Hoopes, and T. Hasan, “Pretreatment photosensitizer dosimetry reduces variation in tumor response.,” Int J Radiat Oncol Biol Phys, vol. 64, no. 4, pp. 1211–1220, Mar. 2006.
  • X. Zhou, B. Chen, P. J. Hoopes, T. Hasan, and B. W. Pogue, “Tumor vascular area correlates with photosensitizer uptake: analysis of verteporfin microvascular delivery in the Dunning rat prostate tumor.,” Photochem Photobiol, vol. 82, no. 5, pp. 1348–1357, Oct. 2006.
  • D. Yelin, I. Rizvi, W. M. White, J. T. Motz, T. Hasan, B. E. Bouma, and G. J. Tearney, “Three-dimensional miniature endoscopy.,” Nature, vol. 443, no. 7113, Oct. 2006.
  • N. Solban, P. K. Selbo, A. K. Sinha, S. K. Chang, and T. Hasan, “Mechanistic investigation and implications of photodynamic therapy induction of vascular endothelial growth factor in prostate cancer.,” Cancer Res, vol. 66, no. 11, pp. 5633–5640, Jun. 2006.
  • N. Solban, I. Rizvi, and T. Hasan, “Targeted photodynamic therapy.,” Lasers Surg Med, vol. 38, no. 5, pp. 522–531, Jun. 2006.
  • A. K. Sinha, S. Anand, B. J. Ortel, Y. Chang, Z. Mai, T. Hasan, and E. V. Maytin, “Methotrexate used in combination with aminolaevulinic acid for photodynamic killing of prostate cancer cells.,” Br J Cancer, vol. 95, no. 4, pp. 485–495, Aug. 2006.
  • K. O’Riordan, D. S. Sharlin, J. Gross, S. Chang, D. Errabelli, O. E. Akilov, S. Kosaka, G. J. Nau, and T. Hasan, “Photoinactivation of Mycobacteria in vitro and in a new murine model of localized Mycobacterium bovis BCG-induced granulomatous infection.,” Antimicrob Agents Chemother, vol. 50, no. 5, pp. 1828–1834, May 2006.
  • B. Kosharskyy, N. Solban, S. K. Chang, I. Rizvi, Y. Chang, and T. Hasan, “A mechanism-based combination therapy reduces local tumor growth and metastasis in an orthotopic model of prostate cancer.,” Cancer Res, vol. 66, no. 22, pp. 10953–10958, Nov. 2006.
  • S. Kosaka, S. Kawana, C. C. Zouboulis, T. Hasan, and B. Ortel, “Targeting of sebocytes by aminolevulinic acid-dependent photosensitization.,” Photochem Photobiol, vol. 82, no. 2, pp. 453–457, Apr. 2006.
  • S. L. Gibbs, B. Chen, J. A. O’Hara, P. J. Hoopes, T. Hasan, and B. W. Pogue, “Protoporphyrin IX level correlates with number of mitochondria, but increase in production correlates with tumor cell size.,” Photochem Photobiol, vol. 82, no. 5, pp. 1334–1341, Oct. 2006.
  • B. Chen, B. W. Pogue, J. M. Luna, R. L. Hardman, P. J. Hoopes, and T. Hasan, “Tumor vascular permeabilization by vascular-targeting photosensitization: effects, mechanism, and therapeutic implications.,” Clin Cancer Res, vol. 12, no. 3 Pt 1, pp. 917–923, Feb. 2006.
  • B. Chen, B. W. Pogue, P. J. Hoopes, and T. Hasan, “Vascular and cellular targeting for photodynamic therapy.,” Crit Rev Eukaryot Gene Expr, vol. 16, no. 4, 2006.
  • A. Casas, C. Perotti, B. Ortel, G. Di Venosa, M. Saccoliti, A. Batlle, and T. Hasan, “Tumor cell lines resistant to ALA-mediated photodynamic therapy and possible tools to target surviving cells.,” Int J Oncol, vol. 29, no. 2, Aug. 2006.
  • O. E. Akilov, S. Kosaka, K. O’Riordan, X. Song, M. Sherwood, T. J. Flotte, J. W. Foley, and T. Hasan, “The role of photosensitizer molecular charge and structure on the efficacy of photodynamic therapy against Leishmania parasites.,” Chem Biol, vol. 13, no. 8, pp. 839–847, Aug. 2006.

2005

  • N. Solban, B. Ortel, B. Pogue, and T. Hasan, “Targeted optical imaging and photodynamic therapy.,” Ernst Schering Res Found Workshop, no. 49, pp. 229–258, 2005.
  • M. D. Savellano and T. Hasan, “Photochemical targeting of epidermal growth factor receptor: a mechanistic study.,” Clin Cancer Res, vol. 11, no. 4, pp. 1658–1668, Feb. 2005.
  • K. O’Riordan, O. E. Akilov, and T. Hasan, “The potential for photodynamic therapy in the treatment of localized infections.,” Photodiagnosis Photodyn Ther, vol. 2, no. 4, pp. 247–262, Dec. 2005.
  • S. A. G. Lambrechts, T. N. Demidova, M. C. G. Aalders, T. Hasan, and M. R. Hamblin, “Photodynamic therapy for Staphylococcus aureus infected burn wounds in mice.,” Photochem Photobiol Sci, vol. 4, no. 7, pp. 503–509, Jul. 2005.
  • M. G. del Carmen, I. Rizvi, Y. Chang, A. C. E. Moor, E. Oliva, M. Sherwood, B. Pogue, and T. Hasan, “Synergism of epidermal growth factor receptor-targeted immunotherapy with photodynamic treatment of ovarian cancer in vivo.,” J Natl Cancer Inst, vol. 97, no. 20, pp. 1516–1524, Oct. 2005.
  • B. Chen, B. W. Pogue, X. Zhou, J. A. O’Hara, N. Solban, E. Demidenko, P. J. Hoopes, and T. Hasan, “Effect of tumor host microenvironment on photodynamic therapy in a rat prostate tumor model.,” Clin Cancer Res, vol. 11, no. 2 Pt 1, pp. 720–727, Jan. 2005.
  • B. Chen, B. W. Pogue, P. J. Hoopes, and T. Hasan, “Combining vascular and cellular targeting regimens enhances the efficacy of photodynamic therapy.,” Int J Radiat Oncol Biol Phys, vol. 61, no. 4, pp. 1216–1226, Mar. 2005.
  • B. Chen, B. W. Pogue, and T. Hasan, “Liposomal delivery of photosensitising agents.,” Expert Opin Drug Deliv, vol. 2, no. 3, pp. 477–487, May 2005.

2004

  • X. Zhou, B. W. Pogue, B. Chen, and T. Hasan, “Analysis of effective molecular diffusion rates for verteporfin in subcutaneous versus orthotopic Dunning prostate tumors.,” Photochem Photobiol, vol. 79, no. 4, pp. 323–331, Apr. 2004.
  • M. R. Hamblin and T. Hasan, “Photodynamic therapy: a new antimicrobial approach to infectious disease?,” Photochem Photobiol Sci, vol. 3, no. 5, pp. 436–450, May 2004.
  • I. Georgakoudi, N. Solban, J. Novak, W. L. Rice, X. Wei, T. Hasan, and C. P. Lin, “In vivo flow cytometry: a new method for enumerating circulating cancer cells.,” Cancer Res, vol. 64, no. 15, pp. 5044–5047, Aug. 2004.
  • F. Gad, T. Zahra, T. Hasan, and M. R. Hamblin, “Effects of growth phase and extracellular slime on photodynamic inactivation of gram-positive pathogenic bacteria.,” Antimicrob Agents Chemother, vol. 48, no. 6, pp. 2173–2178, Jun. 2004.
  • F. Gad, T. Zahra, K. P. Francis, T. Hasan, and M. R. Hamblin, “Targeted photodynamic therapy of established soft-tissue infections in mice.,” Photochem Photobiol Sci, vol. 3, no. 5, pp. 451–458, May 2004.

2003

  • M. D. Savellano and T. Hasan, “Targeting cells that overexpress the epidermal growth factor receptor with polyethylene glycolated BPD verteporfin photosensitizer immunoconjugates.,” Photochem Photobiol, vol. 77, no. 4, pp. 431–439, Apr. 2003.
  • B. W. Pogue, J. A. O’Hara, E. Demidenko, C. M. Wilmot, I. A. Goodwin, B. Chen, H. M. Swartz, and T. Hasan, “Photodynamic therapy with verteporfin in the radiation-induced fibrosarcoma-1 tumor causes enhanced radiation sensitivity.,” Cancer Res, vol. 63, no. 5, pp. 1025–1033, Mar. 2003.
  • K. Jung, H.-W. Krell, B. Ortel, T. Hasan, A. Romer, D. Schnorr, S. A. Loening, and M. Lein, “Plasma matrix metalloproteinase 9 as biomarker of prostate cancer progression in Dunning (Copenhagen) rats.,” Prostate, vol. 54, no. 3, pp. 206–211, Feb. 2003.
  • M. R. Hamblin, J. L. Miller, I. Rizvi, H. G. Loew, and T. Hasan, “Pegylation of charged polymer-photosensitiser conjugates: effects on photodynamic efficacy.,” Br J Cancer, vol. 89, no. 5, pp. 937–943, Sep. 2003.
  • M. R. Hamblin, T. Zahra, C. H. Contag, A. T. McManus, and T. Hasan, “Optical monitoring and treatment of potentially lethal wound infections in vivo.,” J Infect Dis, vol. 187, no. 11, pp. 1717–1725, Jun. 2003.
  • B. Chen, B. W. Pogue, I. A. Goodwin, J. A. O’Hara, C. M. Wilmot, J. E. Hutchins, P. J. Hoopes, and T. Hasan, “Blood flow dynamics after photodynamic therapy with verteporfin in the RIF-1 tumor.,” Radiat Res, vol. 160, no. 4, pp. 452–459, Oct. 2003.
  • L. G. Sullivan, T. Hasan, M. Wright, H. J. Mankin, and C. A. Towle, “Photodynamic treatment has chondroprotective effects on articular cartilage.,” J Orthop Res, vol. 20, no. 2, pp. 241–248, Mar. 2002.
  • B. Ortel, D. Sharlin, D. O’Donnell, A. K. Sinha, E. V. Maytin, and T. Hasan, “Differentiation enhances aminolevulinic acid-dependent photodynamic treatment of LNCaP prostate cancer cells.,” Br J Cancer, vol. 87, no. 11, pp. 1321–1327, Nov. 2002.

2002

  • M. R. Hamblin, D. A. O’Donnell, N. Murthy, K. Rajagopalan, N. Michaud, M. E. Sherwood, and T. Hasan, “Polycationic photosensitizer conjugates: effects of chain length and Gram classification on the photodynamic inactivation of bacteria.,” J Antimicrob Chemother, vol. 49, no. 6, pp. 941–951, Jun. 2002.
  • M. R. Hamblin, D. A. O’Donnell, N. Murthy, C. H. Contag, and T. Hasan, “Rapid control of wound infections by targeted photodynamic therapy monitored by in vivo bioluminescence imaging.,” Photochem Photobiol, vol. 75, no. 1, pp. 51–57, Jan. 2002.
  • R. Haimovici, T. A. Ciulla, J. W. Miller, T. Hasan, T. J. Flotte, A. G. Kenney, K. T. Schomacker, and E. S. Gragoudas, “Localization of rose bengal, aluminum phthalocyanine tetrasulfonate, and chlorin e6 in the rabbit eye.,” Retina, vol. 22, no. 1, Feb. 2002.
  • L. R. Duska, J. Wimberly, T. F. Deutsch, B. Ortel, J. Haas, K. Houck, and T. Hasan, “Detection of female lower genital tract dysplasia using orally administered,” Gynecol Oncol, vol. 85, no. 1, pp. 125–128, Apr. 2002.

2001

  • N. S. Soukos, M. R. Hamblin, S. Keel, R. L. Fabian, T. F. Deutsch, and T. Hasan, “Epidermal growth factor receptor-targeted immunophotodiagnosis and photoimmunotherapy of oral precancer in vivo.,” Cancer Res, vol. 61, no. 11, pp. 4490–4496, Jun. 2001.
  • B. W. Pogue, B. Ortel, N. Chen, R. W. Redmond, and T. Hasan, “A photobiological and photophysical-based study of phototoxicity of two chlorins.,” Cancer Res, vol. 61, no. 2, pp. 717–724, Jan. 2001.
  • T. Heitner, A. Moor, J. L. Garrison, C. Marks, T. Hasan, and J. D. Marks, “Selection of cell binding and internalizing epidermal growth factor receptor antibodies from a phage display library.,” J Immunol Methods, vol. 248, no. 1–2, Feb. 2001.
  • M. R. Hamblin, J. L. Miller, I. Rizvi, B. Ortel, E. V. Maytin, and T. Hasan, “Pegylation of a chlorin(e6) polymer conjugate increases tumor targeting of photosensitizer.,” Cancer Res, vol. 61, no. 19, pp. 7155–7162, Oct. 2001.

2000

  • U. Schmidt-Erfurth and T. Hasan, “Mechanisms of action of photodynamic therapy with verteporfin for the treatment of age-related macular degeneration.,” Surv Ophthalmol, vol. 45, no. 3, Dec. 2000.
  • K. L. Molpus, M. R. Hamblin, I. Rizvi, and T. Hasan, “Intraperitoneal photoimmunotherapy of ovarian carcinoma xenografts in nude mice using charged photoimmunoconjugates.,” Gynecol Oncol, vol. 76, no. 3, Mar. 2000.
  • M. Lein, F. Koenig, J. Misdraji, W. S. McDougal, K. Jung, S. A. Loening, T. Hasan, and B. Ortel, “Laser-induced hyperthermia in rat prostate cancer: role of site of tumor implantation.,” Urology, vol. 56, no. 1, pp. 167–172, Jul. 2000.
  • M. Lein, K. Jung, D. K. Le, T. Hasan, B. Ortel, D. Borchert, B. Winkelmann, D. Schnorr, and S. A. Loenings, “Synthetic inhibitor of matrix metalloproteinases (batimastat) reduces prostate cancer growth in an orthotopic rat model.,” Prostate, vol. 43, no. 2, May 2000.
  • M. R. Hamblin, M. Del Governatore, I. Rizvi, and T. Hasan, “Biodistribution of charged 17.1A photoimmunoconjugates in a murine model of hepatic metastasis of colorectal cancer.,” Br J Cancer, vol. 83, no. 11, pp. 1544–1551, Dec. 2000.
  • M. Del Governatore, M. R. Hamblin, C. R. Shea, I. Rizvi, K. G. Molpus, K. K. Tanabe, and T. Hasan, “Experimental photoimmunotherapy of hepatic metastases of colorectal cancer with a 17.1A chlorin(e6) immunoconjugate.,” Cancer Res, vol. 60, no. 15, pp. 4200–4205, Aug. 2000.
  • M. Del Governatore, M. R. Hamblin, E. E. Piccinini, G. Ugolini, and T. Hasan, “Targeted photodestruction of human colon cancer cells using charged 17.1A chlorin e6 immunoconjugates.,” Br J Cancer, vol. 82, no. 1, Jan. 2000.

1999

  • J. M. Runnels, N. Chen, B. Ortel, D. Kato, and T. Hasan, “BPD-MA-mediated photosensitization in vitro and in vivo: cellular adhesion and beta1 integrin expression in ovarian cancer cells.,” Br J Cancer, vol. 80, no. 7, pp. 946–953, Jun. 1999.
  • B. W. Pogue, T. Momma, H. C. Wu, and T. Hasan, “Transient absorption changes in vivo during photodynamic therapy with pulsed-laser light.,” Br J Cancer, vol. 80, no. 3–4, pp. 344–351, May 1999.
  • J. Khadem, A. A. J. Veloso, F. Tolentino, T. Hasan, and M. R. Hamblin, “Photodynamic tissue adhesion with chlorin(e6) protein conjugates.,” Invest Ophthalmol Vis Sci, vol. 40, no. 13, pp. 3132–3137, Dec. 1999.
  • S. Iinuma, K. T. Schomacker, G. Wagnieres, M. Rajadhyaksha, M. Bamberg, T. Momma, and T. Hasan, “In vivo fluence rate and fractionation effects on tumor response and photobleaching: photodynamic therapy with two photosensitizers in an orthotopic rat tumor model.,” Cancer Res, vol. 59, no. 24, pp. 6164–6170, Dec. 1999.
  • M. R. Hamblin, M. Rajadhyaksha, T. Momma, N. S. Soukos, and T. Hasan, “In vivo fluorescence imaging of the transport of charged chlorin e6 conjugates in a rat orthotopic prostate tumour.,” Br J Cancer, vol. 81, no. 2, pp. 261–268, Sep. 1999.
  • L. R. Duska, M. R. Hamblin, J. L. Miller, and T. Hasan, “Combination photoimmunotherapy and cisplatin: effects on human ovarian cancer ex vivo.,” J Natl Cancer Inst, vol. 91, no. 18, pp. 1557–1563, Sep. 1999.

1998

  • K. B. Trauner, R. Gandour-Edwards, M. Bamberg, S. Shortkroff, C. Sledge, and T. Hasan, “Photodynamic synovectomy using benzoporphyrin derivative in an antigen-induced arthritis model for rheumatoid arthritis.,” Photochem Photobiol, vol. 67, no. 1, pp. 133–139, Jan. 1998.
  • K. Trauner, R. Gandour-Edwards, M. Bamberg, N. S. Nishioka, T. Flotte, S. Autry, and T. Hasan, “Influence of light delivery on photodynamic synovectomy in an antigen-induced arthritis model for rheumatoid arthritis.,” Lasers Surg Med, vol. 22, no. 3, pp. 147–156, 1998.
  • R. G. Statius van Eps, N. R. ChandraSekar, T. Hasan, and G. M. LaMuraglia, “Importance of the treatment field for the application of vascular photodynamic therapy to inhibit intimal hyperplasia.,” Photochem Photobiol, vol. 67, no. 3, pp. 337–342, Mar. 1998.
  • N. S. Soukos, L. A. Ximenez-Fyvie, M. R. Hamblin, S. S. Socransky, and T. Hasan, “Targeted antimicrobial photochemotherapy.,” Antimicrob Agents Chemother, vol. 42, no. 10, pp. 2595–2601, Oct. 1998.
  • B. W. Pogue, R. W. Redmond, N. Trivedi, and T. Hasan, “Photophysical properties of tin ethyl etiopurpurin I (SnET2) and tin octaethylbenzochlorin (SnOEBC) in solution and bound to albumin.,” Photochem Photobiol, vol. 68, no. 6, pp. 809–815, Dec. 1998.
  • B. Ortel, N. Chen, J. Brissette, G. P. Dotto, E. Maytin, and T. Hasan, “Differentiation-specific increase in ALA-induced protoporphyrin IX accumulation in primary mouse keratinocytes.,” Br J Cancer, vol. 77, no. 11, pp. 1744–1751, Jun. 1998.
  • T. Momma, M. R. Hamblin, H. C. Wu, and T. Hasan, “Photodynamic therapy of orthotopic prostate cancer with benzoporphyrin derivative: local control and distant metastasis.,” Cancer Res, vol. 58, no. 23, pp. 5425–5431, Dec. 1998.
  • L. Lilge, K. Molpus, T. Hasan, and B. C. Wilson, “Light dosimetry for intraperitoneal photodynamic therapy in a murine xenograft model of human epithelial ovarian carcinoma.,” Photochem Photobiol, vol. 68, no. 3, pp. 281–288, Sep. 1998.
  • M. R. Hamblin, M. P. Bamberg, J. L. Miller, and T. Hasan, “Cationic photoimmunoconjugates between monoclonal antibodies and hematoporphyrin: selective photodestruction of ovarian cancer cells.,” Appl Opt, vol. 37, no. 31, pp. 7184–7192, Nov. 1998.
  • V. Eps, N.R. ChandraSekar, T. Hasan, G. M. LaMuraglia, “Importance of the treatment field for the application of vascular photodynamic therapy to inhibit intimal hyperplasia.,” Photochemistry and photobiology, vol. 67, no. 3, pp. 337–342, 1998.
  • J. A. Buczek-Thomas, N. Chen, and T. Hasan, “Integrin-mediated adhesion and signalling in ovarian cancer cells.,” Cell Signal, vol. 10, no. 1, Jan. 1998.

1997

  • N. S. Soukos, M. R. Hamblin, and T. Hasan, “The effect of charge on cellular uptake and phototoxicity of polylysine chlorin(e6) conjugates.,” Photochem Photobiol, vol. 65, no. 4, pp. 723–729, Apr. 1997.
  • U. Schmidt-Erfurth, H. Diddens, R. Birngruber, and T. Hasan, “Photodynamic targeting of human retinoblastoma cells using covalent low-density lipoprotein conjugates.,” Br J Cancer, vol. 75, no. 1, 1997.
  • B. W. Pogue, T. Hasan, “A theorectical study of light fractionation and dose rate effects in photodynamic therapy.,” Radiation research, vol. 147, pp. 551–559, 1997.
  • B. W. Pogue, L. Lilge, M. S. Patterson, B. C. Wilson, and T. Hasan, “Absorbed photodynamic dose from pulsed versus continuous wave light examined with tissue-simulating dosimeters.,” Appl Opt, vol. 36, no. 28, pp. 7257–7269, Oct. 1997.
  • B. W. Pogue and T. Hasan, “A theoretical study of light fractionation and dose-rate effects in photodynamic therapy.,” Radiat Res, vol. 147, no. 5, pp. 551–559, May 1997.
  • T. Momma, M. R. Hamblin, and T. Hasan, “Hormonal modulation of the accumulation of 5-aminolevulinic acid-induced protoporphyrin and phototoxicity in prostate cancer cells.,” Int J Cancer, vol. 72, no. 6, pp. 1062–1069, Sep. 1997.
  • R. Haimovici, M. Kramer, J. W. Miller, T. Hasan, T. J. Flotte, K. T. Schomacker, and E. S. Gragoudas, “Localization of lipoprotein-delivered benzoporphyrin derivative in the rabbit eye.,” Curr Eye Res, vol. 16, no. 2, Feb. 1997.
  • L. R. Duska, M. R. Hamblin, M. P. Bamberg, and T. Hasan, “Biodistribution of charged F(ab’)2 photoimmunoconjugates in a xenograft model of   ovarian cancer.,” Br J Cancer, vol. 75, no. 6, pp. 837–844, 1997.

1996

  • K. B. Trauner and T. Hasan, “Photodynamic treatment of rheumatoid and inflammatory arthritis.,” Photochem Photobiol, vol. 64, no. 5, pp. 740–750, Nov. 1996.
  • U. Schmidt-Erfurth, T. J. Flotte, E. S. Gragoudas, K. Schomacker, R. Birngruber, and T. Hasan, “Benzoporphyrin-lipoprotein-mediated photodestruction of intraocular tumors.,” Exp Eye Res, vol. 62, no. 1, Jan. 1996.
  • B. W. Pogue, T. Hasan, “Fluorophore quantitation in tissue-simulating media with confocal detection.,” IEEE journal of quantum electronics, pp. 959–964, 1996.
  • B. Ortel, P. G. Calzavara-Pinton, R. M. Szeimies, and T. Hasan, “Perspectives in cutaneous photodynamic sensitization.,” J Photochem Photobiol B, vol. 36, no. 2, pp. 209–211, Nov. 1996.
  • K. L. Molpus, D. Koelliker, L. Atkins, D. T. Kato, J. Buczek-Thomas, A. F. J. Fuller, and T. Hasan, “Characterization of a xenograft model of human ovarian carcinoma which produces intraperitoneal carcinomatosis and metastases in mice.,” Int J Cancer, vol. 68, no. 5, pp. 588–595, Nov. 1996.
  • K. L. Molpus, D. Kato, M. R. Hamblin, L. Lilge, M. Bamberg, and T. Hasan, “Intraperitoneal photodynamic therapy of human epithelial ovarian carcinomatosis in a xenograft murine model.,” Cancer Res, vol. 56, no. 5, pp. 1075–1082, Mar. 1996.
  • M. Kramer, J. W. Miller, N. Michaud, R. S. Moulton, T. Hasan, T. J. Flotte, and E. S. Gragoudas, “Liposomal benzoporphyrin derivative verteporfin photodynamic therapy. Selective treatment of choroidal neovascularization in monkeys.,” Ophthalmology, vol. 103, no. 3, pp. 427–438, Mar. 1996.
  • M. R. Hamblin, J. L. Miller, and T. Hasan, “Effect of charge on the interaction of site-specific photoimmunoconjugates with human ovarian cancer cells.,” Cancer Res, vol. 56, no. 22, pp. 5205–5210, Nov. 1996.
  • B. A. Goff, J. Blake, M. P. Bamberg, and T. Hasan, “Treatment of ovarian cancer with photodynamic therapy and immunoconjugates in a murine ovarian cancer model.,” Br J Cancer, vol. 74, no. 8, pp. 1194–1198, Oct. 1996.
  • R. Gillies, N. Kollias, T. Hasan, and H. Diddens, “Spectral characterization of the benzoporphyrin derivative monoacid ring-A photoproduct formed in fetal calf solutions during irradiation with 694 nm continuous-wave radiation.,” J Photochem Photobiol B, vol. 33, no. 1, Mar. 1996.
  • L. Cincotta, D. Szeto, E. Lampros, T. Hasan, and A. H. Cincotta, “Benzophenothiazine and benzoporphyrin derivative combination phototherapy effectively eradicates large murine sarcomas.,” Photochem Photobiol, vol. 63, no. 2, pp. 229–237, Feb. 1996.

1995

  • U. Schmidt-Erfurth, T. Hasan, K. Schomacker, T. Flotte, and R. Birngruber, “In vivo uptake of liposomal benzoporphyrin derivative and photothrombosis in experimental corneal neovascularization.,” Lasers Surg Med, vol. 17, no. 2, pp. 178–188, 1995.
  • J. W. Miller, A. W. Walsh, M. Kramer, T. Hasan, N. Michaud, T. J. Flotte, R. Haimovici, and E. S. Gragoudas, “Photodynamic therapy of experimental choroidal neovascularization using lipoprotein-delivered benzoporphyrin.,” Arch Ophthalmol, vol. 113, no. 6, pp. 810–818, Jun. 1995.
  • S. Iinuma, R. Bachor, T. Flotte, and T. Hasan, “Biodistribution and phototoxicity of 5-aminolevulinic acid-induced PpIX in an orthotopic rat bladder tumor model.,” J Urol, vol. 153, no. 3 Pt 1, pp. 802–806, Mar. 1995.
  • L. K. Hu, T. Hasan, E. S. Gragoudas, and L. H. Young, “Photoimmunotherapy of human uveal melanoma cells.,” Exp Eye Res, vol. 61, no. 4, pp. 385–391, Oct. 1995.
  • B. M. Aveline, T. Hasan, and R. W. Redmond, “The effects of aggregation, protein binding and cellular incorporation on the photophysical properties of benzoporphyrin derivative monoacid ring A (BPDMA).,” J Photochem Photobiol B, vol. 30, no. 2–3, pp. 161–169, Oct. 1995.
  • U. Schmidt-Erfurth, T. Hasan, E. Gragoudas, N. Michaud, T. J. Flotte, and R. Birngruber, “Vascular targeting in photodynamic occlusion of subretinal vessels.,” Ophthalmology, vol. 101, no. 12, pp. 1953–1961, Dec. 1994.
  • U. Schmidt-Erfurth, W. Bauman, E. Gragoudas, T. J. Flotte, N. A. Michaud, R. Birngruber, and T. Hasan, “Photodynamic therapy of experimental choroidal melanoma using lipoprotein-delivered benzoporphyrin.,” Ophthalmology, vol. 101, no. 1, Jan. 1994.
  • G. M. LaMuraglia, N. R. ChandraSekar, T. J. Flotte, W. M. Abbott, N. Michaud, and T. Hasan, “Photodynamic therapy inhibition of experimental intimal hyperplasia: acute and chronic effects.,” J Vasc Surg, vol. 19, no. 2, pp. 321–9; discussion 329–331, Feb. 1994.
  • S. Iinuma, S. S. Farshi, B. Ortel, and T. Hasan, “A mechanistic study of cellular photodestruction with 5-aminolaevulinic acid-induced porphyrin.,” Br J Cancer, vol. 70, no. 1, pp. 21–28, Jul. 1994.

1994

  • B. A. Goff, U. Hermanto, J. Rumbaugh, J. Blake, M. Bamberg, and T. Hasan, “Photoimmunotherapy and biodistribution with an OC125-chlorin immunoconjugate in an in vivo murine ovarian cancer model.,” Br J Cancer, vol. 70, no. 3, pp. 474–480, Sep. 1994.
  • R. Bachor, E. Tudor, K. Schomacker, R. Hautmann, and T. Hasan, “Laser-induced fluorescence measurement of the photosensitizer phthalocyanine in two tumor models in vivo.,” Investig Urol (Berl), vol. 5, 1994.
  • R. Bachor, R. Hautmann, and T. Hasan, “Comparison of two routes of photosensitizer administration for photodynamic therapy of bladder cancer.,” Urol Res, vol. 22, no. 1, pp. 21–23, 1994.
  • B. Aveline, T. Hasan, and R. W. Redmond, “Photophysical and photosensitizing properties of benzoporphyrin derivative monoacid ring A (BPD-MA).,” Photochem Photobiol, vol. 59, no. 3, pp. 328–335, Mar. 1994.

1993

  • D. J. Thomas, M. Robinson, P. King, T. Hasan, R. Charlton, J. Martin, T. W. Carr, and D. E. Neal, “p53 expression and clinical outcome in prostate cancer.,” Br J Urol, vol. 72, no. 5 Pt 2, pp. 778–781, Nov. 1993.
  • C. R. Shea, G. A. Olack, H. Morrison, N. Chen, and T. Hasan, “Phototoxicity of lumidoxycycline.,” J Invest Dermatol, vol. 101, no. 3, pp. 329–333, Sep. 1993.
  • W. G. Roberts and T. Hasan, “Tumor-secreted vascular permeability factor/vascular endothelial growth factor influences photosensitizer uptake.,” Cancer Res, vol. 53, no. 1, pp. 153–157, Jan. 1993.
  • G. M. LaMuraglia, P. Ortu, T. J. Flotte, W. G. Roberts, K. T. Schomacker, N. R. ChandraSekar, and T. Hasan, “Chloroaluminum sulfonated phthalocyanine partitioning in normal and intimal hyperplastic artery in the rat. Implications for photodynamic therapy.,” Am J Pathol, vol. 142, no. 6, pp. 1898–1905, Jun. 1993.
  • J. K. Frisoli, E. G. Tudor, T. J. Flotte, T. Hasan, T. F. Deutsch, and K. T. Schomacker, “Pharmacokinetics of a fluorescent drug using laser-induced fluorescence.,” Cancer Res, vol. 53, no. 24, pp. 5954–5961, Dec. 1993.

1992

  • W. G. Roberts and T. Hasan, “Role of neovasculature and vascular permeability on the tumor retention of photodynamic agents.,” Cancer Res, vol. 52, no. 4, pp. 924–930, Feb. 1992.
  • P. Ortu, G. M. LaMuraglia, W. G. Roberts, T. J. Flotte, and T. Hasan, “Photodynamic therapy of arteries. A novel approach for treatment of experimental   intimal hyperplasia.,” Circulation, vol. 85, no. 3, pp. 1189–1196, Mar. 1992.
  • B. A. Goff, R. Bachor, N. Kollias, and T. Hasan, “Effects of photodynamic therapy with topical application of 5-aminolevulinic acid on normal skin of hairless guinea pigs.,” J Photochem Photobiol B, vol. 15, no. 3, pp. 239–251, Aug. 1992.
  • N. Bhatta, R. R. Anderson, T. Flotte, I. Schiff, T. Hasan, and N. S. Nishioka, “Endometrial ablation by means of photodynamic therapy with photofrin II.,” Am J Obstet Gynecol, vol. 167, no. 6, pp. 1856–1863, Dec. 1992.
  • R. Bachor, T. J. Flotte, M. Scholz, S. Dretler, and T. Hasan, “Comparison of intravenous and intravesical administration of chloro-aluminum sulfonated phthalocyanine for photodynamic treatment in a rat bladder cancer model.,” J Urol, vol. 147, no. 5, pp. 1404–1410, May 1992.

1991

  • K. Hanada, R. W. Gange, E. Siebert, and T. Hasan, “Protective effects of cadmium chloride against UVB injury in mouse skin and in cultured human cells: a possible role of cadmium-induced metallothionein.,” Photodermatol Photoimmunol Photomed, vol. 8, no. 3, pp. 111–115, Jun. 1991.
  • B. A. Goff, M. Bamberg, and T. Hasan, “Photoimmunotherapy of human ovarian carcinoma cells ex vivo.,” Cancer Res, vol. 51, no. 18, pp. 4762–4767, Sep. 1991.
  • R. Bachor, C. R. Shea, R. Gillies, and T. Hasan, “Photosensitized destruction of human bladder carcinoma cells treated with chlorin e6-conjugated microspheres.,” Proc Natl Acad Sci U S A, vol. 88, no. 4, pp. 1580–1584, Feb. 1991.
  • R. Bachor, C. R. Shea, S. J. Belmonte, and T. Hasan, “Free and conjugated chlorin E6 in the photodynamic therapy of human bladder carcinoma cells.,” J Urol, vol. 146, no. 6, pp. 1654–1658, Dec. 1991.
  • R. Bachor, M. Scholz, C. R. Shea, and T. Hasan, “Mechanism of photosensitization by microsphere-bound chlorin e6 in human bladder carcinoma cells.,” Cancer Res, vol. 51, no. 16, pp. 4410–4414, Aug. 1991.

1990

  • C. R. Shea, M. E. Sherwood, T. J. Flotte, N. Chen, M. Scholz, and T. Hasan, “Rhodamine 123 phototoxicity in laser-irradiated MGH-U1 human carcinoma cells studied in vitro by electron microscopy and confocal laser scanning microscopy.,” Cancer Res, vol. 50, no. 13, pp. 4167–4172, Jul. 1990.
  • C. R. Shea, Y. Hefetz, R. Gillies, J. Wimberly, G. Dalickas, and T. Hasan, “Mechanistic investigation of doxycycline photosensitization by picosecond-pulsed and continuous wave laser irradiation of cells in culture.,” J Biol Chem, vol. 265, no. 11, pp. 5977–5982, Apr. 1990.
  • B. Ortel, R. W. Gange, and T. Hasan, “Investigations of a manganese-containing mimic of superoxide dismutase in riboflavin phototoxicity in human cells in vitro.,” J Photochem Photobiol B, vol. 7, no. 2–4, pp. 261–276, Nov. 1990.
  • B. Ortel, R. W. Gange, and T. Hasan, “Investigations of a manganese-containing mimic of superoxide dismutase in riboflavin phototoxicity in human cells in vitro,” Photochemistry and photobiology, vol. 7, pp. 261–276, 1990.

1989

  • C. R. Shea, N. Chen, J. Wimberly, and T. Hasan, “Rhodamine dyes as potential agents for photochemotherapy of cancer in human bladder carcinoma cells.,” Cancer Res, vol. 49, no. 14, pp. 3961–3965, Jul. 1989.
  • C. R. Shea, N. Chen, and T. Hasan, “Dynamic aspects of rhodamine dye photosensitization in vitro with an argon-ion laser.,” Lasers Surg Med, vol. 9, no. 2, pp. 83–89, 1989.
  • T. Hasan, “Monoclonal antibody-chromophore conjugates as selective phototoxins,” Journal of controlled release, vol. 10, no. 1, pp. 107–117, 1989.
  • T. Hasan, C. W. Lin, and A. Lin, “Laser-induced selective cytotoxicity using monoclonal antibody-chromophore conjugates.,” Prog Clin Biol Res, vol. 288, pp. 471–477, 1989.

1988

  • C. R. Shea, Y. Hefetz, R. Gillies, J. Wimberly, G. Dalickas, T. Hasan “Doxycycline-sensitized phototoxicity following excimer laser irradiation: effects of irradiance,” Lasers in the Life Sciences, vol. 2, no. 1, 1988.
  • C. R. Shea, D. Whitaker, G. F. Murphy, and T. Hasan, “Ultrastructure and dynamics of selective mitochondrial injury in carcinoma cells after doxycycline photosensitization in vitro.,” Am J Pathol, vol. 133, no. 2, pp. 381–388, Nov. 1988.

1986

  • C. R. Shea, J. Wimberly, and T. Hasan, “Mitochondrial phototoxicity sensitized by doxycycline in cultured human carcinoma cells.,” J Invest Dermatol, vol. 87, no. 3, pp. 338–342, Sep. 1986.
  • A. R. Oseroff, D. Ohuoha, T. Hasan, J. C. Bommer, and M. L. Yarmush, “Antibody-targeted photolysis: selective photodestruction of human T-cell leukemia cells using monoclonal antibody-chlorin e6 conjugates.,” Proc Natl Acad Sci U S A, vol. 83, no. 22, pp. 8744–8748, Nov. 1986.
  • T. Hasan and A. U. Khan, “Phototoxicity of the tetracyclines: photosensitized emission of singlet delta dioxygen.,” Proc Natl Acad Sci U S A, vol. 83, no. 13, pp. 4604–4606, Jul. 1986.
  • T. Hasan, “Photoaffinity labeling of the tetracycline binding site of the escherichia coli ribosome: the use of a high intensity light source and of radioactive sancycline derivatives,” Biochemical pharmacology, vol. 34, no. 7, pp. 1065–1071, 1985.
  • T. Hasan, “Anhydrotetracycline is a major product of tetracycline photolysis,” The Journal of organic chemistry, vol. 50, no. 10, pp. 1755–1757, 1985.
  • T. Hasan, R. A. Goldman, and B. S. Cooperman, “Photoaffinity labeling of the tetracycline binding site of the Escherichia coli ribosome. The uses of a high intensity light source and of radioactive sancycline derivatives.,” Biochem Pharmacol, vol. 34, no. 7, pp. 1065–1071, Apr. 1985.
  • T. Hasan and B. S. Cooperman, “Reversed-phase high-performance liquid chromatographic separations of tetracycline derivatives using volatile mobile phases.,” J Chromatogr, vol. 321, no. 2, pp. 462–466, Mar. 1985.

1984

  • T. Hasan, I. E. Kochevar, D. J. McAuliffe, B. S. Cooperman, and D. Abdulah, “Mechanism of tetracycline phototoxicity.,” J Invest Dermatol, vol. 83, no. 3, pp. 179–183, Sep. 1984.
  • T. Hasan, I. E. Kochevar, and D. Abdulah, “Amiodarone phototoxicity to human erythrocytes and lymphocytes.,” Photochem Photobiol, vol. 40, no. 6, pp. 715–719, Dec. 1984.

1983

  • A. R. Kerlavage, C. J. Weitzmann, T. Hasan, and B. S. Cooperman, “Reversed-phase high-performance liquid chromatography of Escherichia coli ribosomal proteins. Characteristics of the separation of a complex protein mixture.,” J Chromatogr, vol. 266, pp. 225–237, Aug. 1983.
  • A. R. Kerlavage, T. Hasan, and B. S. Cooperman, “Reverse phase high performance liquid chromatography of Escherichia coli ribosomal proteins: standardization of 70 S, 50 S, and 30 S protein chromatograms.,” J Biol Chem, vol. 258, no. 10, pp. 6313–6318, May 1983.
  • T. Hasan, “Heavy atom isotope effect studies of elimination reaction mechanisms: a kinetic and carbon-14 kinetic isotope effect study of the base-promoted dehydrochlorination of substituted 1-Phenylethyl-14C chlorides,” Journal of the American Chemical Society, vol. 105, pp. 3967–3975, 1983.
  • R. A. Goldman, T. Hasan, C. C. Hall, W. A. Strycharz, and B. S. Cooperman, “Photoincorporation of tetracycline into Escherichia coli ribosomes. Identification of the major proteins photolabeled by native tetracycline and tetracycline photoproducts and implications for the inhibitory action of tetracycline on protein synthesis.,” Biochemistry, vol. 22, no. 2, pp. 359–368, Jan. 1983.